Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:10 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.5450 AUD | +1.87% |
|
+3.81% | +36.25% |
| Market Cap | 84.04M 72.66M 68.32M 62.11M 117M 8.02B 119M 800M 313M 4.02B 316M 309M 13.39B | P/E 2026 * |
-0.42x | P/E 2027 * | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 38.85M 33.59M 31.58M 28.71M 53.89M 3.71B 54.86M 370M 145M 1.86B 146M 143M 6.19B | EV / Sales 2026 * |
14.2x | EV / Sales 2027 * | 20.7x |
| Free-Float |
91.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +1.87% | ||
| 1 week | +3.81% | ||
| 1 month | -14.17% | ||
| 3 months | +9.00% | ||
| 6 months | +36.25% | ||
| Current year | +36.25% |
| 1 week | 0.51 |  | 0.6 |
| 1 month | 0.5 | | 0.6 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.78 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.7 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 2021-01-06 |
Abby Macnish
DFI | Director of Finance/CFO | - | 2024-09-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 2005-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 2011-08-07 |
David Stamler
BRD | Director/Board Member | 65 | 2025-11-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/15/26 | Free | Director | 1,000,000 | 0.0092% | ||
| 1/7/26 | Expiration | Chief Executive Officer | 91,392,720 | 0.8404% | ||
| 9/17/25 | Expiration | Director | 7,000,000 | 0.1052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.87% | +3.81% | -16.15% | +36.25% | 82.16M | |
| -1.78% | -0.71% | +2.18% | +13.68% | 49.24B | |
| +0.85% | +2.98% | +464.76% | +579.26% | 43.3B | |
| -2.40% | +5.36% | +13.00% | +75.78% | 40.48B | |
| -2.01% | +1.82% | +24.41% | +7.65% | 39.75B | |
| -0.50% | +3.08% | +19.91% | +47.26% | 32.67B | |
| +0.38% | -1.08% | - | - | 16.23B | |
| -0.59% | -1.11% | +23.61% | +116.76% | 16.24B | |
| +0.49% | +0.80% | +5.45% | +22.29% | 14.04B | |
| -0.43% | +5.48% | +80.68% | +30.58% | 13.43B | |
| Average | -0.41% | +2.12% | +68.65% | +103.28% | 26.55B | |
| Weighted average by Cap. | -0.93% | +2.54% | +95.97% | +133.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.74M 2.37M 2.23M 2.03M 3.8M 262M 3.87M 26.09M 10.21M 131M 10.29M 10.07M 437M | 2.09M 1.8M 1.7M 1.54M 2.9M 199M 2.95M 19.86M 7.77M 99.88M 7.84M 7.66M 332M |
| Net income | -14.75M -12.75M -11.99M -10.9M -20.46M -1.41B -20.83M -140M -54.91M -706M -55.38M -54.17M -2.35B | -29.97M -25.91M -24.36M -22.15M -41.57M -2.86B -42.32M -285M -112M -1.43B -113M -110M -4.77B |
| Net Debt | -45.19M -39.07M -36.74M -33.4M -62.69M -4.31B -63.82M -430M -168M -2.16B -170M -166M -7.2B | -40.88M -35.35M -33.24M -30.22M -56.71M -3.9B -57.73M -389M -152M -1.96B -153M -150M -6.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | A$0.5450 | +1.87% | 359,630 |
| 26-08-13 | A$0.5350 | -4.46% | 309,861 |
| 26-08-12 | A$0.5600 | +3.70% | 983,089 |
| 26-08-11 | A$0.5400 | +0.93% | 13,665 |
| 26-08-10 | A$0.5350 | +3.88% | 47,330 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
